KHKen'Ichi Hagiwara

Ken'Ichi Hagiwara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ken'Ichi Hagiwara has a total of 160 co-authors. Here are the top co-authors by number of shared publications:

  • Terumi Nakajima

    Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Tokyo, Bunkyoku, Tokyo 113, Japan

    12 shared publications
  • Yoshio Yamakawa

    Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

    10 shared publications
  • Tetsutaro Sata

    Department of Pathology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

    8 shared publications
  • Minoru Tobiume

    Department of Pathology National Institute of Infectious Diseases Tokyo Japan

    6 shared publications
  • Hideyuki Hara

    Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

    5 shared publications
  • Kentaro Hanada

    Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan

    5 shared publications

Latest Publications

  • Open Access

    Strain Traits of Intracranially Administered L‐Type Bovine Spongiform Encephalopathy Prions Are not Significantly Modified During Intraspecies Transmission in Cynomolgus Monkeys

    by Ken'IChi Hagiwara, Hiroaki Shibata, Minoru Tobiume, Yuko Sato, Keiko Ohto, Sachi Okabayashi, Nozomi Nakano, Motohiro Horiuchi, Fumiko Ono

    Among the three prion strains of bovine spongiform encephalopathy (BSE), classical BSE (C‐BSE) prions are known causative agents of variant Creutzfeldt–Jakob disease. By contrast, human infections with L‐type (L‐) or H‐type (H‐) BSE prions have not been reported. Nonetheless, the zoonotic potential of L‐BSE prions is supported by their successful primary transmission from cattle to cynomolgus macaque ( Macaca fascicularis ) monkeys via intracranial challenge. To assess whether the defining strain traits of L‐BSE prions remain stable following secondary intraspecies transmission, we prepared brain homogenates from a diseased macaque that had previously undergone primary transmission of L‐BSE prions, and intracranially administered them into two naïve macaques. Both animals succumbed to the disease within humane endpoints comparable to those observed in the primary transmission. Histopathological and immunohistochemical analyses of brain tissues showed no significant changes relative to primary transmission, including severe vacuolation and fine synaptic distribution of disease‐associated forms of prion protein (PrP Sc ) in the cerebrum, and sparse PrP Sc plaques in the cerebellum. In bioassays using C57BL/6 J mice, cattle‐derived L‐BSE prions and those passaged once or twice in macaques failed to transmit to mice, whereas cattle‐derived C‐BSE prions and their macaque‐passaged counterparts were transmissible. These findings refine our understanding of L‐BSE pathogenesis and confirm the stability of L‐BSE prions following intracranial transmission in a nonhuman primate model.

  • Lack of Evidence for Transmission of Atypical H‐Type Bovine Spongiform Encephalopathy Prions (H‐BSE Prions) by Intracranial and Oral Challenges to Nonhuman Primates

    by Hiroaki Shibata, Fumiko Ono, Yuko Sato, Keiko Ohto, Nozomi Nakano, Morikazu Imamura, Motohiro Horiuchi, Minoru Tobiume, Ken'IChi Hagiwara

    Bovine spongiform encephalopathy (BSE) is a prion disease in cattle caused by classical‐type (C‐), L‐type (L‐), or H‐type (H‐) BSE prions. While C‐BSE prions are zoonotic agents responsible for variant Creutzfeldt–Jakob disease, L‐ and H‐BSE prions are believed not to be connected to human prion diseases. However, L‐BSE prions have been shown to transmit to cynomolgus monkeys (Macaca fascicularis), suggesting they may have zoonotic potential. In the present study, we examined whether H‐BSE prions are transmissible to cynomolgus monkeys. The monkeys were injected intracranially (n = 2) or given orally (n = 2) with brain homogenates from a cow infected with H‐BSE prions. After asymptomatic observation periods of 4–6 years, the monkeys were euthanized for autopsy. Histological examination of the brain did not reveal any pathological changes. Immunohistochemical and Western blot analyses did not detect disease‐associated forms of prion protein (PrPSc) in the brain, peripheral neurons, or lymphatic tissues. The unsuccessful transmission indicates an effective barrier against the transmission of cattle H‐BSE prions to cynomolgus monkeys. Based on the results obtained in this nonhuman primate model, we estimated that the potential transmission of H‐BSE prions to humans is substantially lower than C‐ and L‐BSE prions.


  • Open Access

    Tracking and clarifying differential traits of classical- and atypical L-type bovine spongiform encephalopathy prions after transmission from cattle to cynomolgus monkeys

    by Ken'Ichi Hagiwara, Yuko Sato, Yoshio Yamakawa, Hideyuki Hara, Minoru Tobiume, Yuko Okemoto-Nakamura, Tetsutaro Sata, Motohiro Horiuchi, Hiroaki Shibata, Fumiko Ono

    Classical- (C-) and atypical L-type bovine spongiform encephalopathy (BSE) prions cause different pathological phenotypes in cattle brains, and the disease-associated forms of each prion protein (PrPSc) has a dissimilar biochemical signature. Bovine C-BSE prions are the causative agent of variant Creutzfeldt-Jakob disease. To date, human infection with L-BSE prions has not been reported, but they can be transmitted experimentally from cows to cynomolgus monkeys (Macaca fascicularis), a non-human primate model. When transmitted to monkeys, C- and L-BSE prions induce different pathological phenotypes in the brain. However, when isolated from infected brains, the two prion proteins (PrPSc) have similar biochemical signatures (i.e., electrophoretic mobility, glycoforms, and resistance to proteinase K). Such similarities suggest the possibility that L-BSE prions alter their virulence to that of C-BSE prions during propagation in monkeys. To clarify this possibility, we conducted bioassays using inbred mice. C-BSE prions with or without propagation in monkeys were pathogenic to mice, and exhibited comparable incubation periods in secondary passage in mice. By contrast, L-BSE prions, either with or without propagation in monkeys, did not cause the disease in mice, indicating that the pathogenicity of L-BSE prions does not converge towards a C-BSE prion type in this primate model. These results suggest that, although C- and L-BSE prions propagated in cynomolgus monkeys exhibit similar biochemical PrPSc signatures and consist of the monkey amino acid sequence, the two prions maintain strain-specific conformations of PrPSc in which they encipher and retain unique pathogenic traits.


  • Open Access

    Evaluation of rapid post-mortem test kits for bovine spongiform encephalopathy (BSE) screening in Japan: Their analytical sensitivity to atypical BSE prions

    by Ken'IChi Hagiwara, Yoshifumi Iwamaru, Naoko Tabeta, Takashi Yokoyama, Minoru Tobiume

    A classical type of bovine spongiform encephalopathy (C-BSE), recognized in 1987, had a large impact on public health due to its zoonotic link to variant Creutzfeldt-Jakob disease by the human consumption of dietary products contaminated with the C-BSE prion. Thus, a number of countries implemented BSE surveillance using rapid post-mortem test kits that were approved for detection of the C-BSE prion in the cattle brain. However, as atypical BSE (L- and H-BSE) cases emerged in subsequent years, the efficacy of the kits for the detection of atypical BSE prions became a matter of concern. In response to this, laboratories in the European Union and Canada evaluated the kits used in their countries. Here, we carried out an evaluation study of NippiBL®, a kit currently used for BSE screening in Japan. By applying the kit to cattle brains of field cases of C-BSE and L-BSE, and an experimental case of H-BSE, we showed its comparable sensitivities to C, L-, and H-BSE prions, and satisfactory performance required by the European Food Safety Authority. In addition to NippiBL®, two kits (TeSeE® and FRELISA®) formerly used in Japan were effective for detection of the L-BSE prion, although the two kits were unable to be tested for the H-BSE prion due to the discontinuation of domestic sales during this study. These results indicate that BSE screening in Japan is as effective as those in other countries, and it is unlikely that cases of atypical BSE have been overlooked.


  • Open Access

    Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science

    by Ken’ichi Hagiwara, Hideyuki Hara, Kentaro Hanada

    Transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal infectious neurodegenerative disorders. Their causative agents are prions, which are composed of disease-associated forms of prion protein (PrPSc). Naturally occurring cases of TSEs are found in several mammalian species including humans, sheep, goats, minks, cattle and deer. Prions are also experimentally transmissible to other mammals such as mice, hamsters and monkeys, but interspecies transmission is often inefficient due to the ‘species-barrier’. Studies have suggested that the barrier is not only simply determined by differences in amino acid sequences of cellular PrP (PrPC) among animal species, but also by prion strains which are closely associated with conformational properties of PrPSc aggregates. Although the conformational properties of PrPSc remain largely unknown, recent investigation of local structures of PrPC and, in particular, structural modelling of PrPSc aggregates have provided molecular insight into this field. In this review, we discuss the species-barrier phenomenon in terms of the protein science.


  • Mouse Prion Protein (PrP) Segment 100 to 104 Regulates Conversion of PrP C to PrP Sc in Prion-Infected Neuroblastoma Cells

    by Hideyuki Hara, Yuko Okemoto-Nakamura, Fumiko Shinkai-Ouchi, Kentaro Hanada, Yoshio Yamakawa, Ken'Ichi Hagiwara

    Prion diseases are characterized by the replicative propagation of disease-associated forms of prion protein (PrP(Sc); PrP refers to prion protein). The propagation is believed to proceed via two steps; the initial binding of the normal form of PrP (PrP(C)) to PrP(Sc) and the subsequent conversion of PrP(C) to PrP(Sc). We have explored the two-step model in prion-infected mouse neuroblastoma (ScN2a) cells by focusing on the mouse PrP (MoPrP) segment 92-GGTHNQWNKPSKPKTN-107, which is within a region previously suggested to be part of the binding interface or shown to differ in its accessibility to anti-PrP antibodies between PrP(C) and PrP(Sc). Exchanging the MoPrP segment with the corresponding chicken PrP segment (106-GGSYHNQKPWKPPKTN-121) revealed the necessity of MoPrP residues 99 to 104 for the chimeras to achieve the PrP(Sc) state, while segment 95 to 98 was replaceable with the chicken sequence. An alanine substitution at position 100, 102, 103, or 104 of MoPrP gave rise to nonconvertible mutants that associated with MoPrP(Sc) and interfered with the conversion of endogenous MoPrP(C). The interference was not evoked by a chimera (designated MCM2) in which MoPrP segment 95 to 104 was changed to the chicken sequence, though MCM2 associated with MoPrP(Sc). Incubation of the cells with a synthetic peptide composed of MoPrP residues 93 to 107 or alanine-substituted cognates did not inhibit the conversion, whereas an anti-P8 antibody recognizing the above sequence in PrP(C) reduced the accumulation of PrP(Sc) after 10 days of incubation of the cells. These results suggest the segment 100 to 104 of MoPrP(C) plays a key role in conversion after binding to MoPrP(Sc).


  • Open Access

    Experimental Transmission of Bovine Spongiform Encephalopathy (BSE) to Cynomolgus Macaques, a Non-Human Primate

    by Fumiko Ono, Keiji Terao, Naomi Tase, Akio Hiyaoka, Atsushi Ohyama, Yukio Tezuka, Naomi Wada, Asuka Kurosawa, Yuko Sato, Minoru Tobiume, et al.

    Bovine spongiform encephalopathy (BSE) was transmitted to three macaques by intracerebral inoculation of a brain homogenate from affected cattle detected in Japan. All monkeys developed abnormal behavioral signs, such as intermittent anorexia and hyperekplexia, around 24 months after inoculation. Neuronal symptoms, such as tremor, myoclonic jerking, and paralysis, appeared 27–44 months after inoculation. These symptoms worsened and total paralysis ensued within a year after onset. The disease duration was approximately 8–12 months. Both the incubation period and the duration of disease were shortened in the secondary transmission experiment to macaques. Heavy accumulation of disease-causing conformer(s) of prion protein (PrPSc), with a similar glycoform profile to the PrPSc contained in the inoculum, and severe spongiform changes in the histology of the brain, confirmed the successful transmission of BSE to monkeys. Florid plaques, a characteristic histological hallmark of variant Creutzfeldt-Jakob disease, were prominent in the cerebral cortex, in which a prion antigen was detected by immunohistochemistry (IHC). PrPSc was mostly confined to the central nervous system, although small amounts of PrPSc accumulated in the peripheral nerves of monkeys, as detected by Western blotting (WB). Neither IHC nor WB detected PrPSc in the lymphatic organs/tissues, such as the tonsils, spleen, and appendix.


  • Atypical L-Type Bovine Spongiform Encephalopathy (L-BSE) Transmission to Cynomolgus Macaques, a Non-Human Primate

    by Fumiko Ono, Naomi Tase, Asuka Kurosawa, Akio Hiyaoka, Atsushi Ohyama, Yukio Tezuka, Naomi Wada, Yuko Sato, Minoru Tobiume, Ken'IChi Hagiwara, et al.

    A low molecular weight type of atypical bovine spongiform encephalopathy (L-BSE) was transmitted to two cynomolgus macaques by intracerebral inoculation of a brain homogenate of cattle with atypical BSE detected in Japan. They developed neurological signs and symptoms at 19 or 20 months post-inoculation and were euthanized 6 months after the onset of total paralysis. Both the incubation period and duration of the disease were shorter than those for experimental transmission of classical BSE (C-BSE) into macaques. Although the clinical manifestations, such as tremor, myoclonic jerking, and paralysis, were similar to those induced upon C-BSE transmission, no premonitory symptoms, such as hyperekplexia and depression, were evident. Most of the abnormal prion protein (PrPSc) was confined to the tissues of the central nervous system, as determined by immunohistochemistry and Western blotting. The PrPSc glycoform that accumulated in the monkey brain showed a similar profile to that of L-BSE and consistent with that in the cattle brain used as the inoculant. PrPSc staining in the cerebral cortex showed a diffuse synaptic pattern by immunohistochemistry, whereas it accumulated as fine and coarse granules and/or small plaques in the cerebellar cortex and brain stem. Severe spongiosis spread widely in the cerebral cortex, whereas florid plaques, a hallmark of variant Creutzfeldt-Jakob disease in humans, were observed in macaques inoculated with C-BSE but not in those inoculated with L-BSE.


  • Open Access

    HELAS and MadGraph with spin-3/2 particles

    by K. Hagiwara, K. Mawatari, Y. Takaesu


  • Erratum to: Poster Session PPo1: Protein Misfolding

    by Hideyuki Hara, Yuko Okemoto-Nakamura, Fumiko Shinkai-Ouchi, Yoshio Yamakawa, Ken’ichi Hagiwara